Apimeds Pharmaceuticals US, Inc.
Pharmaceutical Preparations · MATAWAN · NJ
Moderate confidence (50%)
Updated Oct 18, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Apimeds Pharmaceuticals US, Inc. received a delisting notice from its exchange (Apr 17, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Apimeds Pharmaceuticals US, Inc. received a delisting notice from its exchange
Apr 17, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On April 17, 2026, Apimeds Pharmaceuticals US, Inc. (the Company ) received a notice from the NYSE Regulation staff of the New York Stock Exchange ( NYSE ) indicating that the Company is not in compliance with NYSE s continued listing requirements under the timely filing criteria outlined in Section 1007 of the NYSE American Listed Company Manual as a result of the Company s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the Form 10…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker APUS on NYSE.
- SEC CIK
- 0001894525
- Website
- —
- —
- Headquarters
- MATAWAN, NJ
- Also known as
- —
- Legal entities
- Apimeds Pharmaceuticals US, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Apimeds Pharmaceuticals US, Inc. — Pharmaceutical Preparations (SIC 2834) — MATAWAN, NJ
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . On April 17, 2026, Apimeds Pharmaceuticals US, Inc. (the Company ) received a notice from the NYSE Regulation staff of the New York Stock Exchange ( NYSE ) indicating that the Company is not in compliance with NYSE s continued listing requirements under the timely filing criteria outlined in Section 1007 of the NYSE American Listed Company Manual as a result of the Company s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the Form 10…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:05 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.